Lenalidomide Maintenance in Plasma Cell Myeloma

Clinical trial NCT02538198 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02538198
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2015-08-31
Primary completion: 2026-08-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.